|
[1]
|
中国知网. Globocan2022全球癌症统计数据解读[EB/OL].
https://link.cnki.net/urlid/11.9298.R.20240620.1056.024, 2024-07-18.
|
|
[2]
|
Vasiliauskas, D., Hancock, S. and Stern, C.D. (1999) SWiP-1: Novel SOCS Box Containing WD-Protein Regulated by Signalling Centres and by SHH during Development. Mechanisms of Development, 82, 79-94.
https://www.sciencedirect.com/science/article/pii/S0925477399000143
|
|
[3]
|
Choi, D.W., Seo, Y., Kim, E., Sung, K.S., Ahn, J.W., Park, S., et al. (2008) Ubiquitination and Degradation of Homeodomain-Interacting Protein Kinase 2 by WD40 Repeat/SOCS Box Protein WSB-1. Journal of Biological Chemistry, 283, 4682-4689. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Wang, Y., et al. (2015) WDSPdb: A Database for WD40-Repeat Proteins. Nucleic Acids Research, 43, D339-D344.
https://pubmed.ncbi.nlm.nih.gov/25348404/
|
|
[5]
|
Villamil, M.A., Liang, Q. and Zhuang, Z. (2013) The WD40-Repeat Protein-Containing Deubiquitinase Complex: Catalysis, Regulation, and Potential for Therapeutic Intervention. Cell Biochemistry and Biophysics, 67, 111-126. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christoffolete, M.A., Kim, B.W., et al. (2005) The Hedgehog-Inducible Ubiquitin Ligase Subunit WSB-1 Modulates Thyroid Hormone Activation and PTHrP Secretion in the Developing Growth Plate. Nature Cell Biology, 7, 698-705. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kim, J.J., et al. (2015) WSB1 Promotes Tumor Metastasis by Inducing pVHL Degradation. Genes & Development, 29, 2244-2257.
https://www.semanticscholar.org/paper/WSB1-promotes-tumor-metastasis-by-inducing-pVHL-Kim-Lee/176bb297b2bab75f463d99cdca16673abaffa097
|
|
[8]
|
Kim, J.J., et al. (2017) WSB1 Overcomes Oncogene-Induced Senescence by Targeting ATM for Degradation. Cell Research, 27, 274-293.
https://www.nature.com/articles/cr2016148
|
|
[9]
|
Smith, T.F., Gaitatzes, C., Saxena, K. and Neer, E.J. (1999) The WD Repeat: A Common Architecture for Diverse Functions. Trends in Biochemical Sciences, 24, 181-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Haque, M., Kendal, J.K., MacIsaac, R.M. and Demetrick, D.J. (2016) WSB1: From Homeostasis to Hypoxia. Journal of Biomedical Science, 23, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hilton, D.J., Richardson, R.T., Alexander, W.S., Viney, E.M., Willson, T.A., Sprigg, N.S., et al. (1998) Twenty Proteins Containing a C-Terminal SOCS Box Form Five Structural Classes. Proceedings of the National Academy of Sciences of the United States of America, 95, 114-119. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2015) Cancer Statistics, 2015. CA: A Cancer Journal for Clinicians, 65, 5-29. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhu, Y., Feng, B., Mei, L., et al. (2019) Clinical Efficacy of TACE Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 24, 608-614.
|
|
[14]
|
El-Serag, H.B. and Rudolph, K.L. (2007) Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis. Gastroenterology, 132, 2557-2576. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Xu, H., Han, H. and Tian, G. (2020) High Expression of WSB1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma and Affects Epithelial-Mesenchymal Transition. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 25, 1890-1896.
|
|
[16]
|
Tong, Y., Li, Q., Xing, T., Zhang, M., Zhang, J. and Xia, Q. (2013) HIF1 Regulates WSB‐1 Expression to Promote Hypoxia‐induced Chemoresistance in Hepatocellular Carcinoma Cells. FEBS Letters, 587, 2530-2535. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Boldrini, L. and Bardi, M. (2023) WSB1 Involvement in Prostate Cancer Progression. Genes, 14, Article 1558. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. and Thun, M.J. (2003) Cancer Statistics, 2003. CA: A Cancer Journal for Clinicians, 53, 5-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Li, D.H., Xie, K.P., Wolff, R. and Abbruzzese, J.L. (2004) Pancreatic Cancer. Lancet, 363, 1049-1057.
https://pubmed.ncbi.nlm.nih.gov/15051286/
|
|
[21]
|
Postier, R.G. (2003) The Challenge of Pancreatic Cancer. The American Journal of Surgery, 186, 579-582. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Archange, C., Nowak, J., Garcia, S., Moutardier, V., Calvo, E.L., Dagorn, J., et al. (2008) The WSB1 Gene Is Involved in Pancreatic Cancer Progression. PLOS ONE, 3, e2475. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Smith, M.A., et al. (2010) Outcomes for Children and Adolescents with Cancer: Challenges for the Twenty-First Century. Journal of Clinical Oncology, 28, 2625-2634.
https://pubmed.ncbi.nlm.nih.gov/20404250/
|
|
[24]
|
Shichrur, K., Feinberg-Gorenshtein, G., Luria, D., Ash, S., Yaniv, I. and Avigad, S. (2014) Potential Role of WSB1 Isoforms in Growth and Survival of Neuroblastoma Cells. Pediatric Research, 75, 482-486. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Ritter, J. and Bielack, S.S. (2010) Osteosarcoma. Annals of Oncology, 21, vii320-vii325. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Bakhshi, S. and Radhakrishnan, V. (2010) Prognostic Markers in Osteosarcoma. Expert Review of Anticancer Therapy, 10, 271-287. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Cao, J., Wang, Y., Dong, R., Lin, G., Zhang, N., Wang, J., et al. (2015) Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells. Cancer Research, 75, 4839-4851. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ma, N., Xu, E., Luo, Q. and Song, G. (2023) Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. Molecules, 28, Article 2976. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Ma, L., Zhang, Y. and Hu, F. (2020) Mir-28-5p Inhibits the Migration of Breast-Cancer by Regulating WSB2. International Journal of Molecular Medicine, 46, 1562-1570. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Li, J.H., et al. (2019) Five-Year Lung Cancer Mortality Risk Analysis and Topography in Xuan Wei: A Spatiotemporal Correlation analysis. BMC Public Health, 19, Article No. 173.
https://pubmed.ncbi.nlm.nih.gov/30744631/
|
|
[31]
|
魏学强. WSB2在宣威肺癌增殖及迁移中的作用及机制研究[D]: [博士学位论文]. 昆明: 昆明医科大学, 2021.
|
|
[32]
|
Li, X., Zhang, C., Lin, X., Zhang, J., Zhang, Y., Yu, H., et al. (2024) Elevated Expression of WSB2 Degrades P53 and Activates the IGFBP3-AKT-mTOR-Dependent Pathway to Drive Hepatocellular Carcinoma. Experimental & Molecular Medicine, 56, 177-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Lens, M.B. and Dawes, M. (2004) Global Perspectives of Contemporary Epidemiological Trends of Cutaneous Malignant Melanoma. British Journal of Dermatology, 150, 179-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Atallah, E. and Flaherty, L. (2005) Treatment of Metastatic Malignant Melanoma. Current Treatment Options in Oncology, 6, 185-193. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhang, Y., Li, Z., Zhao, W., Hu, H., Zhao, L., Zhu, Y., et al. (2019) WD Repeat and SOCS Box Containing Protein 2 in the Proliferation, Cycle Progression, and Migration of Melanoma Cells. Biomedicine & Pharmacotherapy, 116, Article ID: 108974. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Nabirye, J., Okwi, L.A., Nuwematsiko, R., Kiwanuka, G., Muneza, F., Kamya, C., et al. (2020) Health System Factors Influencing Uptake of Human Papilloma Virus (HPV) Vaccine among Adolescent Girls 9-15 Years in Mbale District, Uganda. BMC Public Health, 20, Article No. 171. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
白云, 熊艳杰, 吴颖露, 等. Wsb2在宫颈癌中的表达及其与临床相关性[J]. 中国煤炭工业医学杂志, 2022, 25(3): 247-251.
|
|
[38]
|
李乔林. Wsb2在非小细胞肺癌中的表达及临床相关性的初步研究[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2020.
|